Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations.
暂无分享,去创建一个
E. Peterson | T. Povsic | P. Goldschmidt-Clermont | J. Kherani | Katherine L. Zavodni | E. Vainorius
[1] M. Hristov,et al. High-reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3- lymphocyte sub-population. , 2008, JIM - Journal of Immunological Methods.
[2] E. Peterson,et al. Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. , 2007, Journal of the American College of Cardiology.
[3] M. Yoder,et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. , 2007, Experimental hematology.
[4] M. Shibuya,et al. Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. , 2007, Blood.
[5] A. Balber,et al. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. , 2007, Cytotherapy.
[6] D. Link,et al. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. , 2006, Journal of the American College of Cardiology.
[7] J. Whitesides,et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[8] Doris A Taylor,et al. Circulating endothelial progenitor cells predict coronary artery disease severity. , 2006, American heart journal.
[9] H. Miller,et al. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. , 2006, Tissue engineering.
[10] G. Nickenig,et al. CD34−/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities , 2006, Circulation research.
[11] G. Nickenig,et al. Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.
[12] A. Scheffold,et al. CD14+CD34low Cells With Stem Cell Phenotypic and Functional Features Are the Major Source of Circulating Endothelial Progenitors , 2005, Circulation research.
[13] S. Fichtlscherer,et al. Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.
[14] A. Avogaro,et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. , 2005, Journal of the American College of Cardiology.
[15] M. Kelm,et al. Impaired progenitor cell activity in age-related endothelial dysfunction. , 2005, Journal of the American College of Cardiology.
[16] J. P. McCoy,et al. Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[17] G. Schatteman. Are circulating CD133+ cells biomarkers of vascular disease? , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[18] G. Nowak,et al. Expression of Vascular Endothelial Growth Factor Receptor-2 or Tie-2 on Peripheral Blood Cells Defines Functionally Competent Cell Populations Capable of Reendothelialization , 2004, Circulation.
[19] G. Wichmann,et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] S. Dimmeler,et al. Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.
[21] U. Ikeda,et al. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease , 2004, Heart.
[22] Hyun-Jae Kang,et al. Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[23] R. Vile,et al. Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood , 2003, Circulation research.
[24] A. Quyyumi,et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.
[25] Christie M. Orschell,et al. Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.
[26] C. Verfaillie,et al. Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.
[27] D. Soligo,et al. Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells , 2001, British journal of haematology.
[28] S. Fichtlscherer,et al. Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.
[29] S. Fichtlscherer,et al. Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease , 2001, Circulation.
[30] S. Rafii,et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.
[31] K. Pantel,et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.
[32] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.